RxDoctor Payments DataLook up a doctor →

Marti Willey

Nurse Practitioner · Encinitas, CANPI 1144574062

Payments from drug & device makers

$36,816in general payments, 2019–2025

Across 1,041 payments — averaging $35.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$10K
  • Novartis$4K
  • Johnson & Johnson$3K
  • Merck$2K
  • Pfizer$1K
  • AstraZeneca$1K
  • plus $16K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead(2 entities)83$10,474
Novartis78$3,521
Johnson & Johnson(2 entities)60$2,638
Merck70$1,501
Pfizer66$1,313
AstraZeneca(2 entities)50$1,226
Sanofi35$1,157
GSK30$878
E.r. Squibb & Sons, L.L.C.31$859
AbbVie30$815
Bristol Myers Squibb38$814
Eisai Inc.20$632
Pharmacyclics LLC, An Abbvie Company24$561
Incyte Corporation21$527
Amgen16$497
Takeda Pharmaceuticals U.S.A., Inc.22$485
Blueprint Medicines Corporation12$481
Daiichi Sankyo Inc.23$447
Bayer22$439
Beigene USA, Inc.17$379
Sobi, Inc13$364
Seagen Inc.18$362
Genentech USA, Inc.15$356
Regeneron Healthcare Solutions, Inc.13$334
Ipsen Biopharmaceuticals, Inc14$312
Array Biopharma Inc19$304
Puma Biotechnology, Inc.12$293
Deciphera Pharmaceuticals Inc.9$281
Pharmaessentia USA Corporation8$258
AVEO Pharmaceuticals, Inc.6$234
EMD Serono, Inc.10$215
Astellas Pharma US Inc7$207
Mirati Therapeutics, Inc.8$202
Rigel Pharmaceuticals, Inc.7$186
Genmab U.S., Inc.7$182
Caris MPI, Inc.2$160
Boehringer Ingelheim6$159
Coherus Oncology, Inc.7$154
ADC Therapeutics America, Inc.5$144
Iovance Biotherapeutics, Inc.4$134
Karyopharm Therapeutics Inc.5$129
Beone Medicines USA, Inc.5$120
Agios Pharmaceuticals, Inc.5$119
Taiho Oncology, Inc.4$108
Geron Corporation4$108
Epizyme, Inc.2$104
Lilly USA, LLC6$104
Exelixis Inc.4$102
Acrotech Biopharma Inc.5$89
Tersera Therapeutics LLC3$86
Cumberland Pharmaceuticals, Inc.5$82
Tactile Systems Technology Inc4$79
Verity Pharmaceuticals Inc.3$78
Octapharma USA, Inc.4$75
Fresenius Kabi USA, LLC3$71
Servier Pharmaceuticals LLC3$70
Jazz Pharmaceuticals Inc.3$63
Menarini Silicon Biosystems, Inc.3$59
Edwards Lifesciences1$58
Accord Healthcare, Inc.3$57

How this compares

$36,816 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Medicare billing

Part B allowed, 2024
$164,451
Medicare patients
186
Services billed
16,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Encinitas

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →